Cocaine (25 mg/kg i.p.) produces analgesia in the rat within 5 min and for a duration of 90 min as determined by the formalin test or for 30 min as determ.ined by the hot plate test. Cocaine analgesia is unaffected by doses of naloxone that are sufficient to attenuate morphine analgesia in both tests. Chlorpromazine (3 mg/kg i.p.), SCH 23390 (100/~g/kg i.p.; a D 1 dopamine receptor antagonist), and eticlopride (75 ~g/kg i.p.; a D 2 dopamine receptor antagonist) each attenuate cocaine analgesia in both tests at doses that alone do not affeet performance in either test. Measurements of blood pressure and heart rate indicate that cocaine analgesia is not due to the activation of baroreceptor reflex afferents. We conclude that cocaine is a supraspinally acting, dopamine-mediated, non-opiate analgesic in the :"at.
INTRODUCTION
The central nervous system action of systemically administered analgesic compounds is thought to be mediated primarily, if not exclusively, by neural mechanisms also activated by opiate receptors 12'!8. Neurons containing norepinephrine and serotonin form essential connecting links in the opiate-activated analgesia mechanism ~2,35. Because cocaine blocks the deactivating re-uptake of biogenic amines in the central nervous system 3°.32, we considered that cocaine might have potent systemic analgesic properties. Furthermore, cocaine's action could bypass opiate receptor mechanisms because it is not an opiate narcotic. ~t has long been known that sympathomimetic agents can produce analgesia 5,25, but we found only 3 short anecdotal reports on the analgesic effect of systemically administered cocaine in dogs 2°'27 and a human ~6. Yang et al. ~6 showed that cocaine applied intranasally attenuated ischemic pain (tourniquet test) in humans, but this effect could not be related securely to a systemic action, and opiate mediation was not tested. We therefore undertook a systematic investigation of cocaine as a systemic analgesic.
MATERIALS AND METHODS
All experiments were conducted using male Sprague-Dawley rats (250-400 g) maintained in facilities fully accredited by the American Association for the Accreditation of Laboratory Animal Care.
Analgesia was evaluated by both the formalin and hot plate tests. In the formalin test 9, 0.05 ml of sterile 5% formalin was injected subcutaneously into the dorsum of one forepaw. Every 5-10 min, pain behavior was graded throughout a 3 min observation period according to the proportion of time (seconds) the paw was held up and licked (grade 3), held fully elevated (grade 2), partially weight bearing (grade 1), or fully weight bearing (grade 0). The sum of the products of each grade and the time spent in that grade was divided by 180 s to yield a pain intensity score. In the hot plate test 22, each rat was placed
